Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Extreme & Uncontrollable Circumstances Application for 2020 Merit-Based Incentive Payment System Reopened

Allison Plitman  |  March 17, 2021

The Centers for Medicare & Medicaid Services reopened the Extreme & Uncontrollable Circumstances application and indicated they will automatically apply the policy to individuals who do not submit data for 2020 Merit-based Incentive Payment System.

Autoantibodies Against LINE-1 p40 May Be More Common in Patients with Active SLE

Vanessa Caceres  |  March 17, 2021

Researchers found nearly all systemic lupus erythematosus (SLE) patients have autoantibodies against long interspersed nuclear elements (LINE-1) p40. These findings suggest LINE-1 may be involved in the pathogenesis of SLE.

New Clinical Trials for Ustekinumab & Denosumab Biosimilars Begin Recruitment

Michele B. Kaufman, PharmD, BCGP  |  March 17, 2021

Clinical trials of biosimilar treatments, including a phase 1 study of SB17, which is biosimilar to ustekinumab, and two phase 3 studies investigating of SB16, which is biosimilar to denosumab, are currently recruiting.

High-Intensity Strength Training May Not Improve OA Knee Pain

Lara C. Pullen, PhD  |  March 17, 2021

High-intensity strength training may be no more beneficial than low-intensity strength training at improving pain and joint compression in patients with knee osteoarthritis, according to a recent study.

Coronavirus Vaccination Assistance

Philip Seo, MD, MHS  |  March 16, 2021

Each state has different requirements for residents to obtain a coronavirus vaccination, with some allowing preregistration and others coordinating vaccinations via employers or the local health department. Below, we list some online resources created to help people determine whether they qualify for coronavirus vaccination and where they should go to schedule an appointment, broken down…

Letter: Lupus Enteritis

Graciela S. Alarcón, MD, MPH, MACR  |  March 15, 2021

I read with interest the case report of a patient with lupus enteritis in the February 2021 issue of The Rheumatologist, and I thought the diagnostic approach and final diagnosis were very well presented; however, I noticed an omission which in my view is quite relevant to this patient’s overall management and to so many…

Rheum After 5: Dr. Mehta, a Rheumatologist & Wheel of Fortune Winner

Carol Patton  |  March 15, 2021

Updated 12/20/2022 to add a video link to the episode. Fire truck. Those are among the favorite words of Jay Mehta, MD, a pediatric rheumatologist and rheumatology fellowship director at Children’s Hospital of Philadelphia.  When he was in high school, Jay appeared on the TV game show, Wheel of Fortune, during My Favorite Teacher week….

Spring 2021’s Awards, Appointments & Announcements in Rheumatology

Gretchen Henkel  |  March 15, 2021

Leigh Callahan, PhD, Now President Elect of United States Bone & Joint Initiative After 20 years of involvement with the U.S. Bone and Joint Initiative (USBJI), Leigh F. Callahan, PhD, Mary Link Briggs Distinguished Professor of Medicine, associate director, Thurston Arthritis Research Center, and director, Osteoarthritis Action Alliance at the University of North Carolina at…

Has the Time Come for Wellness Promotion in Rheumatology?

Larry Beresford   |  March 15, 2021

Despite revolutionary advances in pharmacologic treatments for many rheumatic conditions in recent years, some patients still fail to reach a desired state of living with their disease, notes R. Swamy Venuturupalli, MD, FACR, a clinician and researcher in rheumatology, as well as the founder and director of Attune Health, a Beverly Hills, Calif.-based company that…

Case Report: Mycosis Fungoides in Dermatomyositis

Barrett Ford, MD, Chandana Shilpa Ravipati, DO, & Nirupa Patel, MD  |  March 15, 2021

Dermatomyositis (DM) is an idiopathic inflammatory myopathy involving proximal muscle weakness and skin rash. An associated increased risk of malignancy is well established.1 The most frequent malignancies are related to the ovary, endometrium, lung, gastrointestinal tract, prostate, breast and lymphatics.2 On rare occasions, DM has been reported with certain types of non-Hodgkin’s lymphoma, specifically cutaneous…

  • « Previous Page
  • 1
  • …
  • 153
  • 154
  • 155
  • 156
  • 157
  • …
  • 814
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences